O2 RegenTech awarded $100,000 from Innovation Fund Northeast Ohio

Story excerpt provided by Crain’s Cleveland Business.

O2 RegenTech, a medical device startup out of the University of Akron, has received a boost with $100,000 in funding from the Innovation Fund Northeast Ohio, according to the university.

Founded in 2013 by Nic Leipzig, an associate professor in chemical and biomolecular engineering, O2 RegenTech specializes in wound-care solutions based on technology developed by Leipzig. Andreas Inmann, O2 RegenTech’s president and CEO, helped Leipzig commercialize his work. The company’s primary product, OXAID, is an oxygen-releasing, antimicrobial dressing for the treatment of chronic wounds.

Click here to read the complete article.

Originally published June 27, 2017.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: